PortViewPortView
Tenax Therapeutics logo

Tenax Therapeutics (TENX) Stock Analysis

NASDAQHealthcareBiotechnology

$1.79-0.56%
1-year price historyRange $1.38 – $18.32
52-week range$1.79
$1.31$19.40

What Tenax Therapeutics does

Tenax Therapeutics, Inc. is a specialized pharmaceutical enterprise dedicated to discovering, advancing, and bringing to market therapies for cardiovascular and pulmonary conditions throughout the United States and Canada. Its product pipeline features TNX-103 and TNX-102 (levosimendan), both of which have successfully completed Phase II clinical trials. These compounds are being developed to manage pulmonary hypertension, particularly that linked to heart failure with preserved ejection fraction (HFpEF), as well as other forms of associated pulmonary hypertension. Additionally, the company is progressing TNX-201 (imatinib), a tyrosine kinase inhibitor, designed to treat pulmonary arterial hypertension. Founded in 1967, the organization was initially known as Oxygen Biotherapeutics, Inc. until its rebranding to Tenax Therapeutics, Inc. in September 2014. The company maintains its corporate headquarters in Morrisville, North Carolina.

Key metrics

Market cap
$47.48M
P/E (TTM)
-1.21
EPS (TTM)
$-1.48
Beta
0.93
Dividend yield
0.00%
Revenue / share
$0.00
50-day avg
$10.50
200-day avg
$11.96
52-week high
$19.40
52-week low
$1.31
CEO
Christopher T. Giordano

ETFs linked to TENX

Broad-market and Healthcare sector ETFs an investor holding Tenax Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TENX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TENX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Tenax Therapeutics?
Tenax Therapeutics trades under the ticker TENX on NASDAQ.
Which exchange is TENX listed on?
TENX is listed on NASDAQ.
What sector does Tenax Therapeutics operate in?
Tenax Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze TENX in a portfolio?
PortView shows TENX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.